Abstract:The field of autoimmune diseases in childhood presents challenges to physicians regarding diagnosis, monitoring, and treatment (1)(2)(3). Didactically, autoimmune diseases can be classified as organ-specific or multi-system organ involvement (1)(2)(3).Despite increasing research, the exact cause of autoimmune disorders is not entirely understood (1)(2)(3). The main feature of autoimmune diseases is immune dysregulation which leads to immune-mediated damage of healthy tissues and cells and results from the breakdown of the central or peripheral tolerance (1)(2)(3)(4). Autoimmune diseases in childhood are often less extensively studied (1)(2)(3). In this regard, understanding how autoimmune responses initiate and progress will allow the creation of novel therapeutics and improve the diagnoses and management strategies of these diseases (1)(2)(3).Autoimmune diseases in childhood, in particular, those of early onset (diagnosed at < 5 years of age), have been linked to a series of genetic determinants, including human leukocyte antigen (HLA) and non-HLA variants as well as gene variants related to inborn errors of immunity (5)(6)(7).Inborn errors of immunity (IEI) are genetic disorders that may manifest as increased susceptibility to infections, autoinflammatory, allergic, or malignant diseases, however, there are few IEI in which an autoimmune manifestation has never been observed (6). Regarding this, next-generation sequencing (NGS) has uncovered an array of genetic explanations for autoimmune diseases (6,8). Genetic variants can alter various cellular functions, and the relative risk of each in the disease phenotype's final effect can vary greatly (2,6). An example is the LRBA deficiency which may manifest as a common variable immune deficiency (CVID) as well as inflammatory bowel disease, endocrinopathies, autoimmune hemolytic anemia, thrombocytopenia, arthritis, and systemic lupus erythematosus (8). Another intriguing aspect of autoimmune diseases is that they can occur simultaneously (10). Thus, overt or latent polyautoimmunity is frequently observed in a single patient (10). Like this, Leong et al. reinforce that vitiligo may occur with various other autoimmune diseases such as psoriasis.Classically, autoantibodies are defined as biomarkers of autoimmune disease diagnosis, monitoring, and prediction (10,11). The array of available autoantibodies and Recently, the number of antibody-mediated disorders of the central nervous system

Autoantibodies in immunodeficiency syndromes: The Janus faces of immune dysregulation

Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?

Immunodysregulation in immunodeficiency

Autoimmune Manifestations in Patients with Primary Immunodeficiency.

Auto-immuno-deficiency syndromes

Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia

Cellular pathways and molecular events that shape autoantibody production in COVID-19

Editorial: Autoimmune diseases in childhood

Molecular and cellular mechanisms underlying defective antibody responses

Development of Autoantibodies Precedes Clinical Manifestations of Autoimmune Diseases: A Comprehensive Review.

Gut microbiome profiles and associated metabolic pathways in patients of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies

Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases

Autoimmunity as a continuum in primary immunodeficiency

Cellular and Molecular Mechanisms of Autoimmune Disease

Functional autoantibodies in systemic sclerosis pathogenesis

How underappreciated autoinflammatory (innate immunity) mechanisms dominate disparate autoimmune disorders

Anti-cytokine autoantibodies: mechanistic insights and disease associations

Common Variable Immunodeficiency and Autoimmunity – an Inconvenient Truth

Autoantibodies - enemies, and/or potential allies?

Epigenetics, autoimmunity and hematologic malignancies: a comprehensive review.

The ouroboros of autoimmunity